Tsai Capital Corp Buys 1,152 Shares of Markel Group Inc. $MKL

Tsai Capital Corp raised its stake in Markel Group Inc. (NYSE:MKL) by 47.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,566 shares of the insurance provider’s stock after acquiring an additional 1,152 shares during the quarter. Markel Group makes up approximately 4.8% of Tsai Capital Corp’s investment portfolio, making the stock its 5th largest position. Tsai Capital Corp’s holdings in Markel Group were worth $6,816,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Canerector Inc. raised its position in shares of Markel Group by 191,036.0% in the third quarter. Canerector Inc. now owns 10,703,616 shares of the insurance provider’s stock worth $20,458,463,000 after acquiring an additional 10,698,016 shares during the period. Select Equity Group L.P. lifted its position in shares of Markel Group by 75.9% during the 2nd quarter. Select Equity Group L.P. now owns 336,369 shares of the insurance provider’s stock valued at $671,850,000 after buying an additional 145,146 shares in the last quarter. Norges Bank acquired a new stake in Markel Group in the 2nd quarter valued at approximately $288,361,000. Rakuten Investment Management Inc. acquired a new position in Markel Group during the 3rd quarter worth approximately $46,738,000. Finally, Strive Asset Management LLC purchased a new stake in shares of Markel Group during the 3rd quarter worth $38,227,000. 77.12% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, CEO Simon Wilson sold 100 shares of the firm’s stock in a transaction that occurred on Thursday, February 26th. The shares were sold at an average price of $2,079.48, for a total transaction of $207,948.00. Following the transaction, the chief executive officer directly owned 2,397 shares in the company, valued at approximately $4,984,513.56. This trade represents a 4.00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Steven A. Markel sold 1,330 shares of the stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $2,119.12, for a total transaction of $2,818,429.60. Following the sale, the director owned 60,368 shares of the company’s stock, valued at approximately $127,927,036.16. This represents a 2.16% decrease in their position. The disclosure for this sale is available in the SEC filing. Company insiders own 1.66% of the company’s stock.

Markel Group Stock Performance

NYSE MKL opened at $1,960.09 on Tuesday. The company has a fifty day moving average of $2,073.46 and a two-hundred day moving average of $2,025.06. The company has a market capitalization of $24.66 billion, a PE ratio of 11.55 and a beta of 0.77. Markel Group Inc. has a 1 year low of $1,621.89 and a 1 year high of $2,207.59. The company has a debt-to-equity ratio of 0.23, a current ratio of 0.63 and a quick ratio of 0.63.

Wall Street Analyst Weigh In

A number of research firms have weighed in on MKL. Zacks Research cut Markel Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, January 19th. Weiss Ratings reaffirmed a “buy (b+)” rating on shares of Markel Group in a research report on Monday, December 29th. Finally, Truist Financial increased their price objective on Markel Group from $2,000.00 to $2,100.00 and gave the company a “hold” rating in a report on Friday, February 6th. Two research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $2,100.00.

Markel Group Company Profile

Markel Group (NYSE: MKL) is a diversified insurance holding company best known for underwriting specialty insurance products. Founded in 1930 and headquartered in Richmond, Virginia, the company provides a wide range of commercial property and casualty coverages tailored to niche and hard-to-place risks. Its underwriting operations focus on specialty lines across multiple industries, delivering customized policy structures, program administration, and claims management services for complex exposures.

In addition to primary specialty insurance, Markel operates reinsurance and alternative risk-transfer activities and manages invested assets derived from underwriting float.